ASN008

· Formation Bio, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ASN008, covering 2024-12-27 to 2024-12-27. Get the full timeline:

Most recent: Clinical Trial Update: A Study to Evaluate the Anti-pruritic Effectiveness of ASN008 in Adults With Mild to Moderate Atopic Dermatitis [Phase 2]

See pricing